@article{350bccfae5ec460aa16bb6ba1ba785e4,
title = "Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial",
keywords = "HOMAGE, Spironolactone, Fibrosis, Biomarkers, Study design, PRESERVED EJECTION FRACTION, EXTRACELLULAR-MATRIX TURNOVER, BRAIN NATRIURETIC PEPTIDE, DOUBLE-BLIND, ALDOSTERONE ANTAGONISM, DIASTOLIC DYSFUNCTION, MYOCARDIAL-INFARCTION, COLLAGEN TURNOVER, NT-PROBNP, BIOMARKERS",
author = "Pierpaolo Pellicori and Ferreira, {Joao Pedro} and Beatrice Mariottoni and {Brunner-La Rocca}, Hans-Peter and Ahmed, {Fozia Z.} and Job Verdonschot and Tim Collier and Cuthbert, {Joe J.} and Johannes Petutschnigg and Blerim Mujaj and Nicolas Girerd and Arantxa Gonzalez and Clark, {Andrew L.} and Franco Cosmi and Staessen, {Jan A.} and Stephane Heymans and Roberto Latini and Patrick Rossignol and Faiez Zannad and Cleland, {John G. F.}",
year = "2020",
month = sep,
doi = "10.1002/ejhf.1716",
language = "English",
volume = "22",
pages = "1711--1723",
journal = "European journal of heart failure",
issn = "1388-9842",
publisher = "Wiley",
number = "9",
}